🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How do you turn fragmented scientific workflows into systems that actually work together? Tomorrow at #APIDays, Ajay Subramanian from our Informatics Data Systems team will share how we’re designing digital infrastructure that reflects how science really happens—so researchers

How is AI-driven automation accelerating drug discovery? On May 20, Ilja Kuesters from our Assay Automation and Qualification team will speak at AMG World Events' 5th Annual Future Labs, Automation, and Technology East 2025 Conference. Ilja will highlight how AI is helping our

This #WorldAsthmaMonth, we’re spotlighting GB-0895—our investigational anti-TSLP monoclonal antibody currently in Phase 1. Created with our generative AI platform, GB-0895 was optimized for high potency and extended half-life, with the goal of reducing treatment frequency from

Generate:Together Yesterday, we stepped outside at BoyntonYards for a midweek reset—fueled by great company, fresh air, and food trucks. We’re not just hungry for lunch. We’re hungry for better ways to solve biology’s hardest problems. When Relentlessly Curious and

On the latest #CellAndGenePodcast, our EVP, R&D, Alex Snyder, MD, joins Erin Harris to talk about how we apply generative AI with intention. Alex discusses GB-0895—our TSLP-targeting antibody for asthma designed to extend half-life, improve potency, and reduce dosing frequency.

#TeamGenerate’s Mindset Awards recognize the behaviors that power our science. This time, we’re celebrating the winners of our #AudaciouslyAmbitious Award—honoring bold thinking, disciplined execution, and the drive to go beyond what’s expected. Alex Ayoub, Anil Bhate, Atreyi

What happens when an AI-native company builds a drug development engine for the real world? On the FYI Podcast from ARK Invest, hosts Brett Winton and Nemo M Despot talk with our CEO Mike Nally and CFO Jason Silvers about a system built to optimize not just timelines—but

Pharma isn’t just adopting AI. It’s being redefined by it. Today, our CEO, Mike Nally, joins Pierre Ferragu of New Street Research to open their new speaker series, "AI Transforming Industries". The conversation will explore the infrastructure behind this shift, the programs

Our Andover site is home to one of the largest private CryoEM labs in the country—a place where precision, data, and structural insights fuel progress every day. Recently, they focused on a different kind of precision: bowling. Pins were dropped, scores were settled, and the

AI-driven biopharma deals show no sign of slowing, yet as Andrew Marshall notes in Biopharma Dealmakers (nature), few AI-designed molecules have achieved clinical validation. He highlights Generate:Biomedicines as a "frontrunner," citing our collaboration with Novartis as evidence

From commuting to community, we’re lucky to have a thriving network of cyclists  —from casual riders to serious road warriors. Last week, members of our Bike Committee celebrated the end of #NationalBikeMonth with a group ride from our BoyntonYards HQ in Somerville to

Breakthroughs in biomanufacturing, biochemical modeling, and AI-enabled drug discovery are reshaping the biotech landscape. But they require more than vision—they demand infrastructure, coordination, and technical depth. On June 18, our co-founder and CTO, Gevorg Grigoryan, will

Oncology needs more than new medicines. It needs better ones—designed with intention, built to perform, and developed with the patient in mind. On June 17, our EVP, R&D, Alexandra Snyder, MD, will speak at NYAS' "12th Annual Frontiers in Cancer Immunotherapy Symposium”

What does #PrideMonth look like at a company built for breakthroughs? From our annual tie-dye tradition to a company-wide social hour, #TeamGenerate is coming together this month to celebrate Pride—honoring identity, building connection, and strengthening the culture we are

On Thursday, June 19, at 12:30pm, our CEO, Mike Nally, will join the final panel of #BIO2025: “Going It Alone…or Together?” The panel will explore how nationalism, policy shifts, and economic fragmentation are reshaping global biotech—raising questions about collaboration,

#TeamGenerate thrives on diverse thinking—and today, on International Women in Engineering Day, we honor the incredible contributions of the women engineers whose curiosity, creativity, and expertise power our platform. This year’s theme, #TogetherWeEngineer, reminds us that

Making an impact is in our DNA—whether it's reimagining what medicines can do or supporting the communities we call home. Recently, #TeamGenerate hosted a fundraiser for Horizons to support early education, play spaces, and family services for children experiencing

In her coverage of #BIO2025 (Biotechnology Innovation Organization), Mandy Jackson of Citeline highlights how regulatory uncertainty and market constraints continue to weigh on biotech dealmaking and investment decisions across the industry. Our CEO, Mike Nally, shared our perspective on managing these

For #TeamGenerate, rest is a system feature—built in with the same intention as any part of our platform. Because sustainable progress takes clarity, and because innovation requires space to think, reset, and return with focus. Next week, we pause for our summer shutdown: a